Cord blood stem cell transplantation in primary immune deficiencies

Current Opinion in Allergy and Clinical Immunology

Volumn 7, Issue 6, 2007, Pages 528-534

  Gennery, Andrew R ^a   Cant, Andrew J ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Primary immunodeficiency; Severe combined immunodeficiency; Umbilical cord blood stem cell transplantation

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL MATURATION; CHILD CARE; COMBINED IMMUNODEFICIENCY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HERPES VIRUS; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MESENCHYMAL STEM CELL; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TELOMERE; VIRUS TRANSMISSION;

CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 35948994145     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3282f1d6b6     Document Type: Review

References (39)

1. Gluckman E, Broxmeyer HA, Auerback AD, et al. Hematopoietic reconstitution in a patient with Fanconi anaemia by means of umbilical cord blood from an HLA identical sibling. N Engl J Med 1989; 321:1174-1178.
2. Kleen TO, Kadereit S, Fanning LR, et al. Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation. Transplantation 2005; 80:1316-1322.
3. Encabo A, Solves P, Carbonell-Uberos F, Minana MD. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation. Transfusion 2007; 47:272-279. This study demonstrates phenotypic and functional immaturity of cord blood dendritic cells that may explain why cord blood T lymphocytes become more readily tolerant to host HLA antigens for a given degree of HLA mismatch.
4. + T lymphocytes during primary stimulation. Blood 2003; 102:4608-4617.
5. Lewis NL, Mullaney M, Mangan KF, et al. Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients. Bone Marrow Transplant 2004; 33:71-78.
6. Pipes BL, Tsang T, Peng SX, et al. Telomere length changes after umbilical cord blood transplant. Transfusion 2006; 46:1038-1043. This study is the first to show that, in the recipient, cord blood-derived cells have significantly longer telomeres compared with those derived from peripheral blood, which may have implications for long-term immune function.
7. George TJ, Sugrue MW, George SN, Wingard JR. Factors associated with parameters of engraftment potential of umbilical cord blood. Transfusion 2006; 46:1803-1812. This study examines characteristics of stored cord blood units.
8. Cohen G, Carter SL, Weinberg KI, et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006; 12:1335-1342. This study demonstrates that T lymphocytes already in cord blood may have viral antigen specificity.
9. Van Burik JA, Brunstein CG. Infectious complications following unrelated cord blood transplantation. Vox Sang 2007; 92:289-296. A well-written review of infectious complications following cord blood transplantation.
10. Barker JN, Krepski TP, DeFor TE, et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8:257-260.
11. Nagasawa M, Imai M, Imai K, et al. In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient. Am J Hematol 2000; 65:176-179.
12. Jaing TH, Lee WI, Lin TY, et al. Successful unrelated mismatched cord blood transplantation in an infant with severe combined immunodeficiency and Mycobacterium bovis bacillus Calmette-Guerin disease. Pediatr Transplant 2006; 10:501-504. This case demonstrates successful outcome of UCBSCT in the presence of disseminated bacillus Calmette-Guerin infection.
13. Trahair TN, Wainstein B, Manton N, et al. Rituximab for lymphoproliferative disease prior to haematopoietic stem cell transplantation for X-linked severe combined immunodeficiency. Pediatr Blood Cancer 2007; Epub ahead of print.
14. Kobayashi S, Murayama S, Tatsuzawa O, et al. X-linked severe combined immunodeficiency (X-SCID) with high blood levels of immunoglobulins and Aspergillus pneumonia successfully treated with micafangin followed by unrelated cord blood stem cell transplantation. Eur J Pediatr 2007; 166:207-210.
15. Tsuji Y, Imai K, Kajiwara M, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006; 37:469-477. This study documents the results of seven UCBSCTs for PIDs in a series of 30 patients.
16. Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T cell immunodeficiency disorders: two year experience. J Clin Immunol 2000; 20:446-476.
17. Toren A, Nagler A, Amariglio N, et al. Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency. Bone Marrow Transplant 1999; 23:405-408.
18. Bhattacharya A, Slatter MA, Chapman CE, et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 2005; 36:1-5.
19. Slatter MA, Gennery AR. Umbilical cord stem cell transplantation for primary immunodeficiencies. Expert Opin Biol Ther 2006; 6:555-565. A recent review of UCBSCT for PIDs.
20. Bonduel M, Del Pozo A, Zelaxko M, et al. Successful related umbilical cord blood transplantation for graft failure following T cell depleted non identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplant 1999; 24:437-440.
21. Fagioli F, Biasin E, Berger M, et al. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome. Bone Marrow Transplant 2003; 31:133-136.
22. Myers LA, Michael S, Hershfield MD, et al. Purine nucleoside phosphorylase deficiency (PNP-DEF) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr 2004; 145:710-712.
23. Reubsaet LL, Boelens JJ, Rademaker C, et al. Successful cord blood transplantation in a premature and dysmature neonate of 1700 g with reticular dysgenesis. Bone Marrow Transplant 2007; 39:307-308. Another report documenting successful outcome of UCBSCT in a condition that is difficult to treat.
24. Kernan NA, Schroeder ML, Ciavarella D, et al. Umbilical cord blood infusion in a patient for correction of Wiskott-Aldrich syndrome. Blood Cells 1994; 20:245-248.
25. Knutson AP, Steffen M, Wassmer K, Wall DA. Umbilical cord blood transplantation in Wiskott Aldrich syndrome. J Pediatr 2003; 142:519-523.
26. Kaneko M, Watanabe T, Watanabe H, et al. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease. Int J Hematol 2003; 78:457-460.
27. Kobayashi R, Ariga T, Nonoyama S, et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Haematol 2006; 135:362-366. A large series of 15 patients who underwent UCBSCT for Wiskott-Aldrich syndrome, although specific case details are unavailable.
28. Jaing TH, Tsai BY, Chen SH, et al. Early transplantation of unrelated cord blood in a two-month-old infant with Wiskott-Aldrich syndrome. Pediatr Transplant 2007; 11:557-559.
29. Gross TG, Filipovich AH, Conley ME, et al. Cure of X linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996; 17:741-744.
30. Vowels M, Tang RL, Berdoukas V, et al. Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord blood stem cells. N Engl J Med 1993; 329:1623-1625.
31. Ziegner UHM, Ochs HD, Schanen C, et al. Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr 2001; 138:570-573.
32. Schwinger W, Urban CH, Lackner H, et al. Unrelated 5/6 locus matched umbilical cord blood transplantation in a 23 month old child with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 1998; 22:393-396.
33. Minegishi M, Ohashi Y, Kumaki S, et al. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2001; 27:883-886.
34. Toubo T, Suga N, Ohga S, et al. Successful unrelated cord blood transplantation for Epstein-Barr virus associated lymphoproliferative disease with hemophagocytic syndrome. Int J Hematol 2004; 80:458-462.
35. Radhi M, Rumelhart S, Tatman D, Goldman F. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab. J Pediatr Hematol Oncol 2007; 29:125-127.
36. Benito A, Diaz MA, Alonso F, et al. Successful unrelated umbilical cord blood transplantation in a child with Omenn's syndrome. Pediatr Hematol Oncol 1990; 16:361-366.
37. Meyer-Bahlburg A, Winkler J, Meerback A, et al. Fatal late onset EBV associated post transplant lymphoproliferative disease after umbilical cord blood transplantation due to persistent mixed chimerism and severe delay in T cell recovery in a patient with Omenn's syndrome. Bone Marrow Transplant 2004; 34:283-284.
38. Tomizawa D, Aoki Y, Nagaswa M, et al. Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome. Eur J Haematol 2005; 75:441-444.
39. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335:157-166.